Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G P Browman

Showing results (11-20 of 70) with videos related to

Pageof 7
Sort By:
Cancer Treatment Reports|February 1, 1980
Combination antifol therapy: observations on the development of resistant L1210 leukemic cells in vivoG P Browman, H Lazarus
Seminars in Oncology|June 1, 1994
Standard chemotherapy in squamous cell head and neck cancer: what we have learned from randomized trialsG P Browman, L Cronin
The Canadian Journal of Oncology|March 1, 1995
Implications of using a prognostic index to select therapy for patients with aggressive histology lymphomaR M Meyer, G P Browman
Biochemical Pharmacology|April 15, 1981
Modification of in vivo methotrexate antitumor effect in L1210 leukemia by induced impairment of purine salvageG P Browman, G W Csullog
JAMA|December 20, 1995
The WHO analgesic ladder for cancer pain management. Stepping up the quality of its evaluationA R Jadad, G P Browman
International Journal of Radiation Oncology, Biology, Physics|March 10, 2001
Prophylaxis of oral mucositis in irradiated head-and-neck cancer patients: a proposed classification scheme of interventions and meta-analysis of randomized controlled trialsS E Sutherland, G P Browman
Leukemia Research|January 1, 1992
Predicting remission outcome in acute non-lymphocytic leukemia: general principles and their application to residual marrow leukemiaG P Browman, H D Preisler
World Journal of Surgery|November 7, 1999
Development of clinical practice guidelines: surgical perspectiveM C Brouwers, G P Browman
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2002
Critical appraisal of the Minimal Clinical Recommendations (MCR) of the European Society for Medical Oncology (ESMO): challenges for a European framework for the development of clinical practice guidelinesB Fervers, T Philip, G P Browman
Cancer Chemotherapy and Pharmacology|January 1, 1985
Differential calcium leucovorin protection of human lymphoid cell lines from methotrexateG P Browman, L Booker, P Spiegl
Pageof 7

Showing results (11-20 of 70) with videos related to

Sort By:
Pageof 7
Cancer Treatment Reports|February 1, 1980
Combination antifol therapy: observations on the development of resistant L1210 leukemic cells in vivoG P Browman, H Lazarus
Seminars in Oncology|June 1, 1994
Standard chemotherapy in squamous cell head and neck cancer: what we have learned from randomized trialsG P Browman, L Cronin
The Canadian Journal of Oncology|March 1, 1995
Implications of using a prognostic index to select therapy for patients with aggressive histology lymphomaR M Meyer, G P Browman
Biochemical Pharmacology|April 15, 1981
Modification of in vivo methotrexate antitumor effect in L1210 leukemia by induced impairment of purine salvageG P Browman, G W Csullog
JAMA|December 20, 1995
The WHO analgesic ladder for cancer pain management. Stepping up the quality of its evaluationA R Jadad, G P Browman
International Journal of Radiation Oncology, Biology, Physics|March 10, 2001
Prophylaxis of oral mucositis in irradiated head-and-neck cancer patients: a proposed classification scheme of interventions and meta-analysis of randomized controlled trialsS E Sutherland, G P Browman
Leukemia Research|January 1, 1992
Predicting remission outcome in acute non-lymphocytic leukemia: general principles and their application to residual marrow leukemiaG P Browman, H D Preisler
World Journal of Surgery|November 7, 1999
Development of clinical practice guidelines: surgical perspectiveM C Brouwers, G P Browman
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2002
Critical appraisal of the Minimal Clinical Recommendations (MCR) of the European Society for Medical Oncology (ESMO): challenges for a European framework for the development of clinical practice guidelinesB Fervers, T Philip, G P Browman
Cancer Chemotherapy and Pharmacology|January 1, 1985
Differential calcium leucovorin protection of human lymphoid cell lines from methotrexateG P Browman, L Booker, P Spiegl
Pageof 7